Registration - In-house Corporation

Vaxil Biotherapeutics / David Goren, Chairman and CEO

Registration Information

In-house Corporation name: Vaxil Biotherapeutics
Responsible Officer Name: David Goren, Chairman and CEO
Initial registration start date: 2020-05-05
Registration status: Inactive
Registration Number: 946033-366563

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 1 of 2 (2020-05-05 to 2020-05-05)

Lobbying Information

Subject Matters

Health
Research and Development

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Funding from Strategic Innovation Fund to support COVID-19 vaccine and therapy development clinical trials

Communication Techniques

Written communication
Oral communication

Government Institutions

Health Canada (HC)
Innovation, Science and Economic Development Canada (ISED)
Prime Minister's Office (PMO)

In-house Corporation Details

Description of activities

Biotech company

Responsible officer name and position during the period of this registration

David Goren, Chairman and CEO

Government funding

End date of the last completed financial year: 2019-12-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
Innovation, Science and Economic Development Canada (ISED)	$0.00	Yes

In-house Corporation Contact Information

Address:
3400 One First Canadian Place
Toronto, ON M5X 1A4
Canada

Telephone number: 617-818-2172

Parent Company Information

Vaxil Biotherapeutics is not a subsidiary of any other parent companies.

Subsidiary Beneficiary Information

Vaxil Bio
- Pinchas Sapir Street 3
  Nes Ziona 43556
  Israel

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Gadi Levin, CFO | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Vaxil Biotherapeutics/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Vaxil Biotherapeutics/	2020-05-05	2020-05-05

Vaxil Biotherapeutics

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Vaxil Biotherapeutics / David Goren, Chairman and CEO

Registration Information

Associated Communications

Version 1 of 2 (2020-05-05 to 2020-05-05)

Version 1 of 2 (2020-05-05 to 2020-05-05)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Registration - In-house Corporation

Vaxil Biotherapeutics / David Goren, Chairman and CEO

Version 1 of 2 (2020-05-05 to 2020-05-05)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Vaxil Biotherapeutics/

The following names have been used on or after July 2, 2008

Vaxil Biotherapeutics

David Goren, Chairman and CEO (Corporation)